• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: AD

Behavioural disturbances in AD: topiramate vs. risperidone

April 28, 2010  

SSRIs in Alzheimer’s disease: mixed results

March 30, 2010  

Ginkgo ineffective at preventing cognitive decline

March 30, 2010  

Behavioural symptoms appear improved with prazosin

March 2, 2010  

CSF biomarkers of AD in MCI patients

February 2, 2010  

No cognitive benefit with folate, vitamin B supplementation

February 2, 2010  

Thyroid medication use linked to AD risk

December 1, 2009  

CIHR, Quebec and France collaborate on Alzheimer disease research

October 6, 2009  

Comparing treatments for behavioural and psychological symptoms

August 11, 2009  

Diabetes a risk factor for MCI, Alzheimer’s disease

August 11, 2009  
Previous
5
6
7
8
9
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions